The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals, though skepticism remains.

The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public ...

LOTTE BIOLOGICS (CEO James Park) announced on January 16 that it had presented at the "Asia-Pacific (APAC)" track of the J.P.

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

Reminders of the killing of UnitedHealthcare CEO Brian Thompson were everywhere at this year's J.P. Morgan conference.

At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...

San Francisco law enforcement and city leaders are gearing up for a big month ahead and are warning people to be on alert for ...

It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...

As I ran from interview to interview across San Francisco, I was consistently warmed by the stories I was told by biotech and ...